NCT01910597View on ClinicalTrials.gov

Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

April 20, 2016

Study Completion Date

April 20, 2016

Conditions
Advanced Solid Tumors
Interventions
DRUG

SBG

Trial Locations (1)

90110

Songklanagarind Hospital, Prince of Songkla University, Hat Yai

All Listed Sponsors
lead

Prince of Songkla University

OTHER

NCT01910597 - Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter